Cooperative Roles of Class IA PI3K Isoforms in Translocation-Related Sarcoma Cell Survival and Proliferation

Area of Science:

• Oncology
• Molecular Biology
• Cancer Research

Background:

• Class I phosphatidylinositol 3-kinase (PI3K) signaling pathways are crucial for cancer cell proliferation and survival.
• The specific PI3K isoform driving these processes varies by cancer type and genetic background.
• Translocation-related sarcomas (TRSs) are sensitive to PI3K inhibitors, but the dominant isoform is unknown.

Purpose of the Study:

• To identify the dominant PI3K isoform regulating survival in translocation-related sarcomas (TRSs).
• To investigate the potential of combined PI3K isoform inhibition as a therapeutic strategy for TRSs.

Main Methods:

• Examined roles of individual PI3K isoforms (PI3Kα, PI3Kβ, PI3Kδ) in TRS cell lines.
• Assessed effects of selective and combined PI3K isoform inhibition on Akt/mTOR signaling, apoptosis, and growth.
• Evaluated therapeutic efficacy in a mouse xenograft model.

Main Results:

• PI3Kα inhibition moderately suppressed Akt/mTOR signaling and induced apoptosis in TRS cells.
• PI3Kβ or PI3Kδ inhibition alone had no significant effect.
• Combined inhibition of PI3Kα with PI3Kβ and/or PI3Kδ significantly enhanced apoptosis induction in TRSs.
• PI3Kβ and PI3Kδ compensated for PI3Kα inhibition, highlighting a cooperative survival mechanism in TRSs.
• Triple-isoform inhibition demonstrated superior potency against TRSs in vivo.

Conclusions:

• PI3Kα is the dominant isoform in TRSs, with PI3Kβ and PI3Kδ cooperating in cell survival.
• Simultaneous inhibition of PI3Kα, PI3Kβ, and PI3Kδ represents a potential targeted therapy for translocation-related sarcomas.